Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study


Akkaya C. , Sivrioglu E. Y. , Akgoz S., Eker S. S. , Kirli S.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, vol.21, no.5, pp.337-345, 2006 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 5
  • Publication Date: 2006
  • Doi Number: 10.1002/hup.770
  • Title of Journal : HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
  • Page Numbers: pp.337-345

Abstract

Objective The aim of this study was to compare the efficacy and tolerability of reboxetine in the treatment of major depressive disorder (MDD) and MDD with anxiety features to venlafaxine XR.